Meetings of Nobel Laureates Lindau from Jessica Riccò, 28. June 2010, 18:25 The late morning in Lindau was a non-stop marathon of medical researchers – first Harald zur Hausen talked about the links between infections and cancer, then Luc Montagnier gave an insight into his research that analyzes DNA under physical as well as biological […]
Professor Frazers excellent adventure
Australian Doctor
16 November 2005
An unglamorous quest to discover why HIV-positive men were plagued with anal warts led Professor Ian Frazer to a hugely lauded scientific discovery — a vaccine against cervical cancer. By Bianca Nogrady.
PROFESSOR Ian Frazer radiates energy, albeit an energy tinged with impatience. He may be enthusiastic and talkative throughout this umpteenth media interview, but you can tell he really just wants to get back to his work.
That’s understandable — after all, not only has he led research that could eliminate the spectre of cervical cancer, but he is now on the verge of another breakthrough that has some touting him as Australia’s next Nobel laureate.
Described as “the common cold of sexual activity”, HPV infects an estimated 630 million women around the world, indirectly claiming the lives of about 288,000 each year.
Assessing the effectiveness of human papillomavirus (HPV) vaccination to prevent cervical cancer: perspectives from Germany
J Epidemiol Community Health
February 2010 Vol 64 No 2
For approximately 2 years now, cervical cancer has been “converted” from an oncological disease to an infectious disease, which is said to be preventable by and large by two vaccines licensed in many countries. However, human papillomavirus (HPV) vaccines differ from existing others, as the former target
a condition which only in a minute fraction of infections will lead to serious consequences, but after a long(er) latency period. Furthermore, it should be kept in mind that in clinical trials, the quadrivalent vaccine was tested in fewer than 1200 girls 16 years and younger.1
Parents Warn of HPV Vaccine Dangers
The Epoch Times
By Susanne Larsson
Epoch Times Staff
Sweden
Despite thousands of young girls’ accounts of severe side effects from Gardasil injections, the manufacturer, Merck & Co, Inc., continues to make and sell the vaccine, which is supposed to protect against cervical cancer. Now the girls’ parents warn about the vaccine on their own websites.
According to Natural News Magazine, the Food and Drug Administration (FDA) approved Gardasil for the American market in 2006, and by February 2009, more than 40 million doses had been distributed worldwide.
Gardasil is a vaccine that’s supposed to prevent cervical cancer caused by the human papilloma virus (HPV). The virus spreads through sexual intercourse or skin contact.
September 2, 2010 Approval Letter – Cervarix
FDA – US food and Drug Administration
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration
Rockville, MD 20852-1448
Our STN: BL 125259/98
GlaxoSmithKline Biologicals
Attention: Matthew Whitman
2301 Renaissance Boulevard
P.O. Box 61540
King of Prussia, PA 19406-2772
Dear Mr. Whitman:
We have approved your request to supplement your biologics license application for Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant, to add lymphadenopathy to the Adverse Reactions, Postmarketing Experience section of the full prescribing information.
- « Previous Page
- 1
- …
- 99
- 100
- 101
- 102
- 103
- …
- 114
- Next Page »